DRUGS
   (See also PHARMACIES AND PHARMACISTS; TRAFFIC OFFENSES) |
|
|
Advertising of pharmaceuticals, sale of, B&O tax surcharge, revenue use:
SB 5659 |
|
|
Antibiotics, for Lyme disease, long-term therapy, authority for:
HB 2332 |
|
|
Biological products, interchangeable, confirmation for dispensing of:
*
HB 2251, CH 21 (2020) |
|
|
Cannabidiol products, marijuana retailer sales of:
HB 1238, HB 2300, SB 5201, SB 6269 |
|
|
Cannabis, cannabis science task force, establishing:
*
HB 2052, CH 277 (2019) |
|
|
Cannabis, licensee business practices, benefits, and policies:
HB 2361, SB 6393, SSB 6393 |
|
|
Cannabis, medical use, provisions:
HB 1060, HB 1094,
*
ESHB 1094, CH 203 (2019), HB 1095,
*
SHB 1095, CH 204 (2019), HB 2546, HB 2612, HB 2740, HB 2743, SB 5234, SB 5442, SB 5498, SSB 5498, SB 5599, SB 6332 |
|
|
Cannabis, product testing laboratories, accreditation program for:
*
HB 2052, CH 277 (2019) |
|
|
Cannabis, Washington cannabis commission, and advisory council, creating:
HB 1974, SHB 1974, 2SHB 1974 |
|
|
Cannabis, Washington cannabis commission, creating:
SB 6589 |
|
|
Controlled substance tableting/encapsulating machine, sale/etc., class C felony:
SHB 2375 |
|
|
Controlled substance, endangerment with a, adding fentanyl to crime of:
SB 6022, SSB 6022 |
|
|
Controlled substance, unlawful possession of, reducing to gross misdemeanor:
HB 2835 |
|
|
Controlled substances, illegal consumption in child's presence, sentencing:
HB 1700 |
|
|
Controlled substances, tableting/encapsulating/imitation equipment, prohibitions:
HB 2375, SB 6159 |
|
|
Controlled substances, uniform act, property forfeiture under:
SB 5060 |
|
|
Controlled substances, uniform act, property seizure and forfeiture under:
SB 6266, SSB 6266 |
|
|
Epinephrine autoinjectors, in schools, EpiPen work group, establishing:
HB 2428 |
|
|
Epinephrine autoinjectors, in schools, prescriptions/supplies, report on:
SHB 2428 |
|
|
Fentanyl, adding to crime of endangerment with a controlled substance:
SB 6022, SSB 6022 |
|
|
Fentanyl, manufacture of, moving from drug offense seriousness level II to III:
SB 6583 |
|
|
Food and drug administration, U.S., disclosure exemption for certain records:
*
HB 1385, CH 337 (2019), SB 5455 |
|
|
Illegal drugs, past manufacture on residential property, seller disclosure:
SB 5391, SSB 5391 |
|
|
Illegal use, safe injection sites, prohibiting, and state regulatory preemption:
HB 2112 |
|
|
Illegal use, supervised injection sites, city or county ordinance prohibiting:
HB 2658 |
|
|
Insulin drugs, wholesale price increase notification:
SB 5371 |
|
|
Insulin products, central insulin purchasing work group, establishing:
SB 6113, SSB 6113 |
|
|
Insulin, insurance cost-sharing cap for:
HB 2662, SHB 2662,
*
E2SHB 2662, CH 346 (2020) |
|
|
Insulin, total cost of insulin work group, establishing:
HB 2662, SHB 2662,
*
E2SHB 2662, CH 346 (2020) |
|
|
Marijuana, as contraband on state correctional institution premises:
SHB 1871, 2SHB 1871 |
|
|
Marijuana, business or nonprofit entity, licensing and residency:
HB 1236, SHB 1236, HB 1289, HB 2263, SB 5202, SB 5409, SB 5985, SB 6085 |
|
|
Marijuana, businesses, administrative violations:
HB 1237, SHB 1237, 2SHB 1237, SB 5318,
*
ESSB 5318, CH 394 (2019) |
|
|
Marijuana, businesses, advertising to minors, prohibiting:
HB 1238, HB 2321, SB 5201, SB 6333 |
|
|
Marijuana, businesses, advertising, reducing youth exposure to:
HB 2350, SB 6657 |
|
|
Marijuana, businesses, agreements with, trademarks and intellectual property:
HB 1794,
*
ESHB 1794, CH 380 (2019) |
|
|
Marijuana, businesses, billboards:
HB 1466, HB 2321, HB 2350, SB 5785, SB 6333, SB 6657 |
|
|
Marijuana, businesses, budtender permits for retailers and employees:
HB 1370, SHB 1370, SB 5678 |
|
|
Marijuana, businesses, cannabidiol products:
HB 1238, HB 2300, SB 5201, SB 6269 |
|
|
Marijuana, businesses, compliance and enforcement reform:
HB 1237, SHB 1237, 2SHB 1237, SB 5318,
*
ESSB 5318, CH 394 (2019) |
|
|
Marijuana, businesses, craft marijuana producer license, creating:
HB 2279 |
|
|
Marijuana, businesses, craft marijuana producer/processor license, creating:
HB 2279 |
|
|
Marijuana, businesses, craft marijuana producers/processors advisory group:
HB 2279 |
|
|
Marijuana, businesses, delivery endorsement to retailer license:
HB 1358 |
|
|
Marijuana, businesses, equity loan program and advisory board, creating:
HB 2263, SB 6085 |
|
|
Marijuana, businesses, labor peace agreements:
HB 1289, SB 5985 |
|
|
Marijuana, businesses, license limits in aggregate:
HB 2817, SB 6661 |
|
|
Marijuana, businesses, licensee business practices, benefits, and policies:
HB 2361, SB 6393, SSB 6393 |
|
|
Marijuana, businesses, licensee limits, prohibitions:
HB 1289, SB 5985 |
|
|
Marijuana, businesses, marijuana merchandise:
HB 1238, SB 5201 |
|
|
Marijuana, businesses, marijuana odor, task force on, establishing:
SB 6089 |
|
|
Marijuana, businesses, outdoor advertising at stadium or raceway, when:
SB 5969 |
|
|
Marijuana, businesses, prohibiting licensing due to objection based on zoning:
HB 2247 |
|
|
Marijuana, businesses, qualifying applicant premises, compliance certificate:
HB 2359, SHB 2359, SB 6206,
*
SSB 6206, CH 154 (2020) |
|
|
Marijuana, businesses, retail employee crimes involving underage persons:
*
HB 1792, CH 379 (2019) |
|
|
Marijuana, businesses, retail outlets, maximum number, social equity goals:
HB 2870, SB 6604 |
|
|
Marijuana, businesses, retail outlets, number that may be licensed in state:
HB 2817, SB 6661 |
|
|
Marijuana, businesses, retail outlets, robbery incident details, forwarding:
SB 6033, SSB 6033 |
|
|
Marijuana, businesses, retail outlets, robbery of, special allegation:
SB 6033, SSB 6033 |
|
|
Marijuana, businesses, siting and advertising near children:
HB 1003 |
|
|
Marijuana, businesses, transfers, holding companies, and management:
HB 1289 |
|
|
Marijuana, cannabis science task force, establishing:
*
HB 2052, CH 277 (2019) |
|
|
Marijuana, compliant products, sales and use tax exemptions applicability to:
*
ESSB 5298, CH 393 (2019) |
|
|
Marijuana, cultivation or possession in a residence:
HB 1131, SB 5155 |
|
|
Marijuana, enforcement, powers of liquor enforcement officers:
HB 1626 |
|
|
Marijuana, excise tax distributions for vulnerable persons:
HB 2900 |
|
|
Marijuana, excise tax provisions:
HB 1959, HB 2900 |
|
|
Marijuana, financiers of licensees, money source and criminal history of:
HB 1963 |
|
|
Marijuana, licenses, social equity in marijuana, legislative task force on:
SHB 2870,
*
E2SHB 2870, CH 236 (2020) |
|
|
Marijuana, medical use, compassionate care renewals:
HB 1094,
*
ESHB 1094, CH 203 (2019), SB 5498, SSB 5498 |
|
|
Marijuana, medical use, consumption by students:
HB 1060, HB 1095,
*
SHB 1095, CH 204 (2019), SB 5442 |
|
|
Marijuana, medical use, estimating medical market demand:
SB 5599 |
|
|
Marijuana, medical use, medical marijuana authorization database, funding:
HB 1415,
*
SHB 1415, CH 220 (2019), SB 5482 |
|
|
Marijuana, medical use, recognition cards and excise tax exemption:
HB 2743, SB 5234 |
|
|
Marijuana, medical use, recognition cards and valid authorizations:
HB 2612 |
|
|
Marijuana, medical use, THC concentration:
HB 2546, SB 6332 |
|
|
Marijuana, medical use, various provisions:
HB 2612 |
|
|
Marijuana, medical use, when employer required to have drug-free workplace:
HB 2740 |
|
|
Marijuana, operating watercraft under influence of, criminal offenses:
HB 2431, SHB 2431 |
|
|
Marijuana, possession, misdemeanor convictions, vacation of:
HB 1500, SHB 1500,
*
SB 5605, CH 400 (2019) |
|
|
Marijuana, processor license, forfeiture for failing to be operational, limiting:
HB 2817, SB 6661 |
|
|
Marijuana, producer license, forfeiture for failing to be operational, limiting:
HB 2817, SB 6661 |
|
|
Marijuana, producer license, home delivery endorsement, establishing:
HB 2871, SB 6603 |
|
|
Marijuana, producer license, retail privilege endorsement, establishing:
HB 2871, SB 6603 |
|
|
Marijuana, producer or processor license, direct sales endorsement:
HB 1945, HB 1995 |
|
|
Marijuana, product labels and labeling, requirements:
HB 1250, SB 5298,
*
ESSB 5298, CH 393 (2019) |
|
|
Marijuana, product testing laboratories, accreditation program for:
*
HB 2052, CH 277 (2019) |
|
|
Marijuana, production, square footage of plant canopy permitted in production:
HB 2817, SB 6661 |
|
|
Marijuana, products, infused edible, requiring cold storage or pasteurization:
HB 2726 |
|
|
Marijuana, products, THC concentration, producer/retailer restrictions:
HB 2546, SB 6332 |
|
|
Marijuana, products/infused products, various liquor and marijuana permits:
HB 1945 |
|
|
Marijuana, products/infused products, various provisions:
HB 1945, HB 2726 |
|
|
Marijuana, retail license, for municipal corporation, commission, or authority:
SB 5599 |
|
|
Marijuana, retail license, marijuana consumption lounge special endorsement:
HB 1945 |
|
|
Marijuana, retail licenses, additional, social equity program for:
HB 2870, SB 6604 |
|
|
Marijuana, retail licenses, community of color applicants as priority:
HB 2870, SHB 2870, SB 6604 |
|
|
Marijuana, retail licenses, increasing maximum number, social equity goals:
HB 2870, SB 6604 |
|
|
Marijuana, retail licenses, social equity grant program for:
*
E2SHB 2870, CH 236 (2020) |
|
|
Marijuana, retail licenses, social equity program for:
SHB 2870 |
|
|
Marijuana, retail licenses, technical assistance competitive grant program:
HB 2870, SHB 2870,
*
E2SHB 2870, CH 236 (2020), SB 6604 |
|
|
Marijuana, retailer license, forfeiture for failing to be operational, limiting:
HB 2817, SB 6661 |
|
|
Marijuana, retailers/co-owners, aggregate licenses per business, raising limit:
HB 2817, SB 6661 |
|
|
Marijuana, sales price differentials, permitting, when:
SB 6057 |
|
|
Marijuana, screening tests/results for prospective or newly hired employees:
HB 2740 |
|
|
Marijuana, traceability system, state auditor to audit and report:
HB 2076 |
|
|
Marijuana, use in hotel, motel, or inn guest rooms, unlawful, when:
HB 2199 |
|
|
Marijuana, Washington cannabis commission, and advisory council, creating:
HB 1974, SHB 1974, 2SHB 1974 |
|
|
Marijuana, Washington cannabis commission, creating:
SB 6589 |
|
|
Marketing/advertising to minors via internet/mobile application, prohibitions:
HB 2442 |
|
|
Naloxone, co-prescribing with opioid drug prescription, when:
HB 2337, SB 6447, SSB 6447 |
|
|
Naloxone, grades 5-12 and higher education access:
SSB 5464 |
|
|
Naloxone, grades 7-12 and higher education access:
SB 5464 |
|
|
Naloxone, K-12 and higher education access:
HB 1039, SHB 1039, 2SHB 1039 |
|
|
Offenses, criminal, persons convicted of, resentencing hearings for:
SSB 5848, SB 5867,
*
SSB 5867, CH 55 (2020) |
|
|
Offenses, seizure and forfeiture of property:
HB 1269, SHB 1269 |
|
|
Offenses, seizure and forfeiture of property, recordkeeping and reporting:
SB 6266, SSB 6266 |
|
|
Opioid agonist/antagonist products, medicaid managed care coverage:
HB 2418 |
|
|
Opioid overdose medication, co-prescribing with opioid drug prescription:
HB 2337, SB 6447, SSB 6447 |
|
|
Opioid overdose medication, grades 5-12 and higher education access:
SSB 5464 |
|
|
Opioid overdose medication, grades 7-12 and higher education access:
SB 5464 |
|
|
Opioid overdose medication, high school and higher education access:
*
SSB 5380, CH 314 (2019) |
|
|
Opioid overdose medication, K-12 and higher education access:
HB 1039, SHB 1039, 2SHB 1039 |
|
|
Opioid overdose medication, provisions:
HB 1331, SHB 1331, 2SHB 1331, HB 2337, SB 5380,
*
SSB 5380, CH 314 (2019), SB 6447, SSB 6447 |
|
|
Opioid pollution, reduction permits for pollution control facilities:
SB 5657 |
|
|
Opioid use disorder, medication for, pharmacy use of remote dispensing sites:
SHB 2335,
*
SSB 6086, CH 244 (2020) |
|
|
Opioid use disorder, patients receiving treatment, 2-week medication supply:
HB 2335, SB 6086 |
|
|
Opioid use disorder, persons presenting with, certified peer counselor services:
SSB 6311, 2SSB 6311 |
|
|
Opioid use disorder, persons presenting with, required facility services for:
SB 6311, SSB 6311, 2SSB 6311 |
|
|
Opioids, advisory council on state use of money from litigation, convening:
HB 2786 |
|
|
Opioids, advisory council on state use of penalties from litigation, convening:
ESHB 2786 |
|
|
Opioids, certain practitioners prescribing, limiting liability of, when:
HB 2807 |
|
|
Opioids, prescription, B&O surtax on persons warehousing and reselling:
SB 5940 |
|
|
Opioids, prescription, impact fees, manufacturers to pay, when:
HB 2438, SHB 2438 |
|
|
Opioids/other drugs, crisis services, enhanced 211 drug line pilot project:
SB 5546 |
|
|
Over-the-counter drugs, athletic trainer purchase/administration of, when:
HB 1689, SB 5688,
*
ESSB 5688, CH 358 (2019) |
|
|
Prescription drug affordability board, establishing:
SB 6088,
*
SSB 6088 (2020) V |
|
|
Prescription monitoring program, insulin drug wholesale price increases:
SB 5371 |
|
|
Prescription monitoring program, opioid prescribing and health records:
HB 1331, SHB 1331, 2SHB 1331, SB 5380,
*
SSB 5380, CH 314 (2019) |
|
|
Prescription, advisory council on state use of money from opioid litigation:
HB 2786 |
|
|
Prescription, advisory council on state use of penalties from opioid litigation:
ESHB 2786 |
|
|
Prescription, athletic trainer purchase/administration of, when:
HB 1689, SB 5688,
*
ESSB 5688, CH 358 (2019) |
|
|
Prescription, compounding of drugs, requirements:
HB 1352, SHB 1352, SB 5663 |
|
|
Prescription, cost and utilization data, reporting:
HB 1224, SHB 1224,
*
E2SHB 1224, CH 334 (2019), SB 5251, SB 5292, SSB 5292, 2SSB 5292 |
|
|
Prescription, cost and utilization data, uses/disclosure/requirement dates:
HB 2710 |
|
|
Prescription, cost growth benchmark/data/reviews/transparency/mitigation:
*
SSB 6088 (2020) V |
|
|
Prescription, cost transparency, data uses/disclosure/requirement dates:
HB 2710 |
|
|
Prescription, cost transparency, reporting for:
HB 1224, SHB 1224,
*
E2SHB 1224, CH 334 (2019), SB 5251, SB 5292, SSB 5292, 2SSB 5292, SB 5422 |
|
|
Prescription, covered, maximum point-of-sale cost for:
HB 2464,
*
SHB 2464, CH 116 (2020) |
|
|
Prescription, department of corrections pharmacy, returned medications reuse:
SB 6526,
*
SSB 6526, CH 264 (2020) |
|
|
Prescription, donated open bulk containers or medication cards, reuse:
SB 6526,
*
SSB 6526, CH 264 (2020) |
|
|
Prescription, drug utilization management protocol, use of:
HB 1879,
*
ESHB 1879, CH 171 (2019), SB 5806 |
|
|
Prescription, electronic communication to pharmacy of:
2SHB 1331, SB 5446 |
|
|
Prescription, from Canada, wholesale drug importation program, establishing:
SB 6110 |
|
|
Prescription, high-annual-cost, emerging therapies work group, establishing:
HB 1869, SHB 1869 |
|
|
Prescription, mail order services, unintentional use/enrollment:
SB 5184, SSB 5184 |
|
|
Prescription, medicare, employer group waiver plans, supplemental coverage:
HB 2210, SB 6051,
*
SSB 6051, CH 196 (2020) |
|
|
Prescription, mercury-containing, prohibitions and requirements:
HB 1276 |
|
|
Prescription, naturopath drug and controlled substance prescribing:
SHB 1630 |
|
|
Prescription, naturopath legend drug and controlled substance prescribing:
HB 1630, SB 5752 |
|
|
Prescription, northwest prescription drug consortium, role of:
SB 6113, SSB 6113 |
|
|
Prescription, opioid agonist/antagonist products, medicaid managed care:
HB 2418 |
|
|
Prescription, opioids, impact fees, manufacturers to pay, when:
HB 2438, SHB 2438 |
|
|
Prescription, opioids, prescribing of, requirements:
HB 1331, SHB 1331, 2SHB 1331, HB 2337, SB 5380,
*
SSB 5380, CH 314 (2019), SB 6447, SSB 6447 |
|
|
Prescription, pharmacy tourism programs for obtaining drugs outside U.S.:
SB 6111 |
|
|
Prescription, prescription drug consortium, role of:
HB 2662, SHB 2662,
*
E2SHB 2662, CH 346 (2020) |
|
|
Prescription, psychiatric pharmacist practitioners, role of:
HB 2888, SB 6609 |
|
|
Prescription, psychologists, certification for prescriptive authority:
HB 2967 |
|
|
Prescription, step therapy exception requests:
*
ESHB 1879, CH 171 (2019) |
|
|
Prescription, warehousing/reselling, preferential B&O tax rate, eliminating:
HB 2734 |
|
|
Prescription, warehousing/reselling, preferential B&O tax rate, repealing:
SB 5988 |
|
|
Prescription, wholesale drug importation program, design/implementation of:
SB 6110 |
|
|